Afficher la notice abrégée

hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorAUSTIN, S.
dc.contributor.authorTAOUJI, S.
dc.contributor.authorCHEVET, E.
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorWODRICH, H.
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorRAYNE, F.
dc.date.accessioned2023-07-04T12:02:10Z
dc.date.available2023-07-04T12:02:10Z
dc.date.issued2016
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/183266
dc.description.abstractEnAlphaScreen ® is a technology particularly suitable for bi-molecular inhibitor screening assays, e.g. using protein–protein interactions with purifi ed recombinant proteins. Each binding partner of the bi-molecular interaction is coupled either to donor or to acceptor beads. The technology is based on the quantifi able transfer of oxygen singlets from donor to acceptor microbeads brought together by a specifi c interaction between the partners. We identifi ed the conserved interaction between WW domains of cellular ubiquitin ligases of the Nedd4 family and a short peptide motif (PPxY) present in several structural and nonstructural viral proteins as a potential drug target. Using an AlphaScreen assay recapitulating the interaction between Nedd4.2 and the PPxY motif of the adenoviral capsid protein VI, we screened a library of small molecules and identifi ed specifi c inhibitors of this interaction. © Springer Science+Business Media New York 2016.
dc.language.isoen
dc.publisherHumana Press Inc.
dc.source.titleProteostasis: Methods and Protocolsen_US
dc.subject.en[LP]PxY motif
dc.subject.enAlphaScreen®
dc.subject.enAdenovirus
dc.subject.en384-Well plate
dc.subject.enAntiviral
dc.subject.enHigh-throughput
dc.subject.enProtein-Protein interactions
dc.subject.enSmall-molecule inhibitors
dc.subject.enUbiquitin ligase Nedd4
dc.title.enUsing alphascreen ® to identify small-molecule inhibitors targeting a conserved host–pathogen interaction
dc.typeChapitre d'ouvrageen_US
dc.identifier.doi10.1007/978-1-4939-3756-1_30
dc.subject.halSciences du Vivant [q-bio]/Cancer
bordeaux.page453--467
bordeaux.volume1449
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.institutionCNRS
bordeaux.import.sourcehal
hal.identifierhal-01381397
hal.version1
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exportfalse
workflow.import.sourcehal
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.btitle=Proteostasis:%20Methods%20and%20Protocols&rft.date=2016&rft.volume=1449&rft.spage=453--467&rft.epage=453--467&rft.au=AUSTIN,%20S.&TAOUJI,%20S.&CHEVET,%20E.&WODRICH,%20H.&RAYNE,%20F.&rft.genre=unknown


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée